news
Sanofi to acquire Pluromed, Inc., expanding its presence in biosurgery
16 March 2012 | By Sanofi
Sanofi and Pluromed Inc. have entered into a definitive agreement under which Sanofi is to acquire Pluromed Inc...
List view / Grid view
Sanofi
news
Composition of Sanofi’s Board of Directors
5 March 2012 | By Sanofi
At its meeting held on March 5, 2012, the Board of Directors of Sanofi decided to propose the appointment of a new director...
news
Sanofi demonstrates continued support for patient groups with launch of Patient Group Bursary 2012
5 March 2012 | By Just:: Health PR
Sanofi has signalled its continuing commitment to support patient groups in the UK with the launch of its 2012 Patient Group Bursary...
news
Sanofi appoints Jean-Luc Lowinski, Senior Vice President, Asia Region
2 March 2012 | By Sanofi
Sanofi is pleased to announce the appointment of Jean-Luc Lowinski, as Senior Vice President, Asia Region, effective 1st May...
news
Genzyme begins shipping Fabrazyme from newly approved Framingham manufacturing plant
1 March 2012 | By Sanofi
Genzyme has begun shipping Fabrazyme® (agalsidase beta)...
news
Sanofi and the Institut Pasteur create four prestigious awards to support innovative biomedical research
27 February 2012 | By Sanofi
The creation of the Sanofi-Institut Pasteur Awards announced...
news
Sanofi and Bristol-Myers Squibb collect damages in Plavix patent litigation with Apotex
8 February 2012 | By Bristol-Myers Squibb Company
Apotex has made payment to Sanofi & Bristol-Myers Squibb...
news
Sanofi commits to eliminate or control five neglected tropical diseases
30 January 2012 | By Sanofi
These commitments are a key part of the "Uniting to Combat Neglected Tropical Diseases" partnership...
news
Genzyme announces FDA approval of Framingham manufacturing plant
24 January 2012 | By Sanofi
The FDA has approved its manufacturing plant in Framingham, Mass., for the production of Fabrazyme® (agalsidase beta)...
news
Genzyme announces European approval of Framingham manufacturing plant
18 January 2012 | By Sanofi
Sanofi & Genzyme announced that the EMA has approved its manufacturing plant in Framingham....
news
Sanofi and Venture Capital Firms, Third Rock Ventures and Greylock Partners, jointly launch Warp Drive Bio
10 January 2012 | By Sanofi
Sanofi is co-investing in Warp Drive Bio, an innovative start-up biotechnology company...
news
Sanofi reports positive results for once-daily Lyxumia® (lixisenatide) in Combination with Lantus® (insulin glargine) in Type 2 Diabetes
6 December 2011 | By Sanofi
Data from phase III GetGoal Duo 1 study...
news
Sanofi confirms its decades-long commitment to the fight against Malaria
29 November 2011 | By Sanofi
Sanofi organizes the 10th Edition of the Pan-African Conference against Malaria with representatives of 34 African Countries...
news
Genzyme announces successful Phase III results for Alemtuzumab (LEMTRADA) in multiple sclerosis
14 November 2011 | By Sanofi
The Phase lll CARE-MS ll trial met both of its co-primary endpoints...
news
Sanofi and Regeneron report positive preliminary Phase 2 program results
10 November 2011 | By Sanofi
Sanofi and Regeneron Pharmaceuticals, Inc. announced positive preliminary results from the Phase 2 study program...
